ASX - Delayed Quote AUD
Next Science Limited (NXS.AX)
0.0870
+0.0050
+(6.10%)
At close: 3:55:15 PM GMT+10
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Cash Flows from Used in Operating Activities Direct
-7,963.4040
-7,963.4040
-15,058.9960
-11,789.7700
-8,264.3540
Investing Cash Flow
-589.2180
-589.2180
-884.5030
-475.7160
-716.7580
Financing Cash Flow
1,751.8990
1,751.8990
20,107.6360
10,247.2970
1,426.7810
End Cash Position
1,673.9170
1,673.9170
9,238.6970
5,111.4140
7,367.9980
Capital Expenditure
-589.2180
-589.2180
-884.4690
-475.7160
-716.7580
Issuance of Capital Stock
--
--
14,035.5760
10,886.1600
1,645.7700
Issuance of Debt
2,000
2,000
--
--
--
Repurchase of Capital Stock
2.5940
2.5940
-637.8620
-385.6340
-6.2300
Free Cash Flow
-8,552.6220
-8,552.6220
-15,943.4650
-12,265.4860
-8,981.1120
12/31/2021 - 4/18/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VIT.AX Vitura Health Limited
0.0680
-2.86%
PER.AX PERCHERON FPO [PER]
0.0100
0.00%
IVX.AX Invion Limited
0.0830
+1.22%
IDT.AX IDT Australia Limited
0.0980
-2.00%
RGT.AX Argent BioPharma Limited
0.1100
0.00%
VLS.AX Vita Life Sciences Limited
1.8000
0.00%
LGP.AX Little Green Pharma Ltd
0.1050
-8.70%
BOD.AX Bod Science Limited
0.0240
0.00%
EPN.AX Epsilon Healthcare Limited
0.0240
0.00%
MVP.AX Medical Developments International Limited
0.6100
+5.17%